Status:
ACTIVE_NOT_RECRUITING
The RAPID COVID-19 TRIAGE Algorithm
Lead Sponsor:
Ottawa Heart Institute Research Corporation
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
This study is being conducted to study the use and application of a point-of-care (POC) Covid-19 test developed by Spartan BioSciences and recently approved for clinical use by Health Canada. Phase I ...
Detailed Description
Currently, testing for COVID-19 is carried out with swabs and blood tests that are sent to hospital laboratories for analysis. With the current technology, the turnaround time for test results may tak...
Eligibility Criteria
Inclusion
- Patients ≥ 18 yo referred to the cardiology, internal medicine, ICU, CICU, CSICU or RACE teams who have tested positive for COVID-19.
Exclusion
- Patients in whom conventional COVID-19 testing would not have otherwise been instituted or in whom immediate test results would not alter short-term treatment, Patients with pre-existing wishes for DNR.
Key Trial Info
Start Date :
June 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 28 2026
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT04353154
Start Date
June 15 2020
End Date
June 28 2026
Last Update
December 11 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Ottawa Heart Institute
Ottawa, Ontario, Canada, K1N 4W7